$26.50
-2.94-9.99%
At close: -
$26.50
00.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Instil Bio (NASDAQ:TIL) Stock, Earnings Estimates, EPS, And Revenue
Instil Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-2.550
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Instil Bio using advanced sorting and filters.
Data brought to you by Benzinga APIs
Instil Bio (TIL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $-2.55 | $-2.10 | -21.4 % |
| Jun 2024 | 2024-08-13 | $-2.29 | $-2.98 | 23.2 % |
| Mar 2024 | 2024-05-10 | $-2.39 | $-2.23 | -7.17 % |
| Dec 2023 | 2024-03-21 | $-1.26 | $-2.85 | 55.8 % |
Instil Bio (TIL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2022 | 2023-03-31 | $0 | $500.00K | -100.0 % |
FAQ
When is Instil Bio (NASDAQ:TIL) reporting earnings?
Instil Bio ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Instil Bio (NASDAQ:TIL)?
Instil Bio ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was $-2.55, which missed the estimate of $-2.10.
What were Instil Bio’s (NASDAQ:TIL) revenues?
Instil Bio ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.